Pemigatinib, a selective FGFR inhibitor overcomes ABCB1-mediated multidrug resistance in cancer cells
Chao Zhang, Min-na Huang, Junqi Shan, Zun-Jie Hu, Ziwei Li, Jian-ying Liu
Topics & Concepts
Multiple drug resistanceFibroblast growth factor receptorIntracellularCancer researchP-glycoproteinDrug resistancePharmacologyBiologyReceptorCell biologyBiochemistryFibroblast growth factorMicrobiologyDrug Transport and Resistance MechanismsFibroblast Growth Factor ResearchPancreatic and Hepatic Oncology Research